cd-573161 Review TG-4010 (Transgene). Cohen S Kaufman HL Current ...
The total number of adverse events (AEs) reported was 71 and were .... Patent Commentary There are no patents that spec ifically relate to TG-4010, however,
... including BLP-25 (Biomira Inc), a MUC-1 peptide-based liposomal vaccine in
...
http://www.biomedcentral.com/content/download/xml/cd-573161....
|
Merck Annual Report 2003 english - Online Version
a number of years, was kept on the previous year's level at EUR 605 million. ...... (L-BLP-25) being studied in collaboration with Biomira in non-small cell
..... ally expand our patent portfolio in LCD technology. A total investment of
...
http://www.merck.de/company.merck.de/en/images/Merck_AR_2003...
|
Updated english press release
against cancer, including Aphton (USA), Epimmune (USA), Biomira (USA) and Progenics. (USA). As is the case with a number of other technologies in the
field of ..... GemVax holds a total of 42 national patents, which it has
obtained ...
http://www.rr-research.no/general/docs/PDF/148177.pdf...
|
Microsoft PowerPoint - Lehman_3_2007
Total: EUR 8213 million. 1 Combined data; not audited; no pro-forma consolidation; .... In April 2006, Biomira announced final survival results of a
phase .... More than 2500 patents for LC singles, mixtures and display
applications ... According to IAS 33 EPS is calculated on the average weighted
number of shares ...
http://www.merck.de/company.merck.de/en/images/Lehman_3_2007...
|
Microsoft PowerPoint - Deutsche Bank Tokyo SB RB 14.05.07
Total: € 8213 million. 1 Combined data; not audited; no pro-forma ..... Supported by over 2500 patents claiming chemical compounds, mixtures and ....
According to IAS 33 EPS is calculated on the average weighted number of shares
.... 3 Exclusive worldwide licensing rights acquired from Biomira Inc., Canada,
...
http://www.merck.de/company.merck.de/en/images/Deutsche-Bank...
|
Microsoft PowerPoint - Citi Merck NY SB RB presentation 22.05.07 FINAL
Total: € 6398 million. 1 Combined data; not audited; no pro-forma ..... Supported by over 2500 patents claiming chemical compounds, mixtures and ....
According to IAS 33 EPS is calculated on the average weighted number of shares
.... 3 Exclusive worldwide licensing rights acquired from Biomira Inc., Canada,
...
http://www.merck.de/company.merck.de/en/images/Citi-Merck-NY...
|
Annual Report | 2001
licensing of Theratope® from Biomira further expands our impressive oncology pipeline. ...... At Merck, the number of basic patent applications has
drastically ...... in 2001, contributing 31% to total Laboratory Distribution
sales. ...
http://www.merck.de/company.merck.de/en/images/Merck_AR_2001...
|
